Drug
DBPR108 clinical trials
Also written DBPR108.
- studies test it
- 10
- open now
- 0
- in phase 3
- 1
- first study started
- 2012
How studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
10 studies that test it; most in 2021 (6)
| Year | Studies |
|---|---|
| 2012 | 1 |
| 2014 | 1 |
| 2020 | 1 |
| 2021 | 6 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 9
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 8 · Other 2
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (8) · National Health Research Institutes, Taiwan (2)
Often tested with
Tested in the same studies.
Warfarin (1) · Digoxin (1) · Probenecid (1) · Metformin (1) · Glyburide (1) · Valsartan (1) · Simvastatin (1)
Studies
Open first, then newest update. How each study uses DBPR108 is read from its arms, and is right about nine times in ten.
Testing it · 10
- A Study to Evaluate the Pharmacokinetics and Safety of DBPR108 in Subjects With Hepatic ImpairmentCompletedPhase 1CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT04859426Written as DBPR108 tablets
- A Study to Evaluate the Effect of Different Meal Types on the Pharmacokinetics of DBPR108 in Healthy SubjectsCompletedPhase 1CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT05150626Written as DBPR108 tablets
- A Study to Evaluate the Pharmacokinetics and Safety of DBPR108 in Subjects With Renal ImpairmentCompletedPhase 1CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT04859439Written as DBPR108 tablets
- A Single-dose and Multiple-dose Study to Evaluate the Pharmacokinetics and Pharmacodynamics of DBPR108 Tablets in Type 2 Diabetes Mellitus PatientsCompletedPhase 1CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT05146869Written as DBPR108 tablets
- A Study to Evaluate the Drug-drug Interactions (DDIs) of DBPR108 With Warfarin Sodium, Digoxin, Probenecid in Healthy SubjectsCompletedPhase 1CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT05045313Written as DBPR108 tablets
- Mass Balance and Biotransformation Study of [14C]DBPR108 in HumanCompletedPhase 1CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT05072028Written as [14C]DBPR108
- A Study to Evaluate the DDI of DBPR108 With Metformin,Glibenclamide,Valsartan, or Simvastatin in Healthy SubjectsCompletedPhase 1CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT04859452Written as DBPR108 tablets
- A Study of DBPR108 and Metformin Hydrochloride Combination Therapy in Patients With T2DMCompletedPhase 3CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT04218734Written as DBPR108
- A Multiple Ascending Dose Phase I Study of DBPR108 in Healthy Male SubjectsCompletedPhase 1National Health Research Institutes, TaiwanNCT02163278Written as DBPR108
- A Single-dose Phase 1 Study of DBPR108 in Healthy Male SubjectsCompletedPhase 1National Health Research Institutes, TaiwanNCT01650324Written as DBPR108